According to a recent report published by Grand View Research, Inc., the global cell and gene therapy bioanalytical testing services market is projected to reach a valuation of USD 828.7 million by the year 2030. The market is expected to grow at a compound annual growth rate (CAGR) of 7.3% from 2024 to 2030. This growth is being driven primarily by several key factors, including...